Radius Health (NASDAQ:RDUS) reported Q1 earnings this Morning, coming in at ($1.37) per share, beating Wall Street’s estimates of ($1.46) per Share. Revenue for the quarter came in at $14.50 million beating analyst estimates of $13.80 million Recent Insider Trading for Radius Health (NASDAQ:RDUS)
- On 4/19/2018 Growth N V Biotech, Major Shareholder, bought 40,000 with an average share price of $33.80 per share and the total transaction amounting to $1,352,000.00.
- On 4/5/2018 Growth N V Biotech, Major Shareholder, bought 50,000 with an average share price of $36.58 per share and the total transaction amounting to $1,829,000.00.
- On 3/2/2018 Growth N V Biotech, Major Shareholder, bought 80,000 with an average share price of $32.52 per share and the total transaction amounting to $2,601,600.00.
- On 2/9/2018 Growth N V Biotech, Major Shareholder, bought 75,000 with an average share price of $34.38 per share and the total transaction amounting to $2,578,500.00.
- On 11/14/2017 Growth N V Biotech, Major Shareholder, bought 50,000 with an average share price of $26.25 per share and the total transaction amounting to $1,312,500.00.
- On 11/10/2017 Brent Hatzis-Schoch, VP, bought 1,778 with an average share price of $28.09 per share and the total transaction amounting to $49,944.02.
Dividend History for Radius Health (NASDAQ:RDUS)
Recent Trading for Radius Health (NASDAQ:RDUS) Shares of Radius Health closed the previous trading session at 33.00 up +0.99 3.09% with 28469 shares trading hands.